Marcio Souza bought $60k of PRAX
Chief Executive Officer at Praxis Precision Medicines, Inc.. 70,002 shares at an average of $0.86, traded Mar 23, 2023, filed Mar 27, 2023.
Score components
- +25RoleCEO
- +7Trade size$60k at market
- +6Relative to holdingsHoldings up 37%
- +18Price context0% above the 52-week low; 93% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-23-037023, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 23, 2023 | POpen-market purchase Common Stock | +35,000 | $0.86 | $30k | 226,299 | Mar 27, 2023 |
| Mar 23, 2023 | POpen-market purchase Common Stockindirect: Held by spouse | +35,002 | $0.86 | $30k | 35,002 | Mar 27, 2023 |
Related signals
Other insiders at Praxis Precision Medicines, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Praxis Precision Medicines, Inc. | Jill DeSimone director | $3.6M 11,600 shares | -83% | |
| 53Moderate | Praxis Precision Medicines, Inc. | Lauren Mastrocola Principal Accounting Officer | $2.6M 13,600 shares | -57% | |
| 53Moderate | Praxis Precision Medicines, Inc. | Alex Nemiroff General Counsel and Secretary | $4.9M 25,130 shares | -55% | |
| 42Moderate | PRAXsell Praxis Precision Medicines, Inc. | Adage Capital Management, L.P. owner | $33M 313,910 shares | -13% | |
| 34Weak | Praxis Precision Medicines, Inc. | Lauren Mastrocola Principal Accounting Officer | $424k 5,188 shares | -48% | |
| 38Weak | Praxis Precision Medicines, Inc. | Alex Nemiroff General Counsel and Secretary | $661k 8,239 shares | -44% | |
| 39Weak | PRAXbuy Praxis Precision Medicines, Inc. | Marcio Souza Chief Executive Officer | $11k 10,000 shares | +29% | |
| 61Notable | Praxis Precision Medicines, Inc. | Timothy Edwin Kelly Chief Financial Officer | $6,998 8,000 shares | +21% | |
| 61Notable | Praxis Precision Medicines, Inc. | Timothy Edwin Kelly Chief Financial Officer | $6,998 8,000 shares | +21% | |
| 64Notable | Praxis Precision Medicines, Inc. | Dean J Mitchell director | $42k 50,000 shares | +200% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.